Get started
Author

Frank Richard

Patterns of chromosomal imbalances in invasive breast cancer
2000 · Frank Richard, Manuela Pacyna-Gengelbach, et al. · International Journal of Cancer · 100
Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteers
2019 · Frank Richard, Jan Jaap van Lier, et al. · American Journal of Hematology · 77
PDF
Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q
1998 · A Schwendel, F Richard, et al. · British Journal of Cancer · 62
PDF
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma
2016 · Eric D. Bateman, Udo-Michael Goehring, et al. · Journal of Allergy and Clinical Immunology · 52
A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD
2016 · Marc Miravitlles, Jéssica Montero-Caballero, et al. · International Journal of COPD · 45
PDF
Roflumilast for the Treatment of COPD in an Asian Population
2013 · Jinping Zheng, Jinghua Yang, et al. · CHEST Journal · 39
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development
2021 · John Porter, Ali Taher, et al. · Expert Review of Hematology · 30
PDF
Effect of tiotropium on COPD exacerbations: A systematic review
2016 · David M.G. Halpin, Claus Vogelmeier, et al. · Respiratory Medicine · 25
PDF
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction—Results of the CHIARA MIA 1 Trial
2018 · Hans‐Dirk Düngen, Lars Kober, et al. · Clinical Pharmacology in Drug Development · 21
Bayesian Strategies in Rare Diseases
2022 · Ursula Garczarek, Natalia Muehlemann, et al. · Therapeutic Innovation & Regulatory Science · 17
PDF
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study
2025 · Antonis Kattamis, Ali Taher, et al. · Orphanet Journal of Rare Diseases · 9
PDF
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
2020 · Uwe Zeymer, Christiane Lober, et al. · Cardiology and Therapy · 8
PDF
Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone
2011 · Hartmut Blode, Christine Klipping, et al. · Contraception · 7
The Anti-BCMA Antibody-Drug Conjugate Hdp-101 with a Novel Amanitin Payload Shows Promising Initial First in Human Results in Relapsed Multiple Myeloma
2024 · Robert Z. Orlowski, Shambavi Richard, et al. · Blood · 6
Tiotropium Respimat® Versus HandiHaler®: Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials
2016 · Peter M. A. Calverley, Michael Könen-Bergmann, et al. · Advances in Therapy · 5
PDF
Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradiol/Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone
2012 · Herbert Wiesinger, Urte Eydeler, et al. · Clinical Drug Investigation · 5
Innovative Adaptive Study Design in Transfusion-Dependent Beta-Thalassemia: Bayesian Design with Concurrent Randomization and Borrowing from Historical Data
2021 · Natalia Muehlemann, Rajat Mukherjee, et al. · Blood · 2
The Anti-BCMA Antibody-Drug Conjugate HDP-101 with a Novel Amanitin Payload Shows Promising Data in Relapsed/Refractory Multiple Myeloma in a Phase 1/2a Clinical Trial as it Advances into Cohort 7
2025 · Hajnalka Szaboki, Jonathan L. Kaufman, et al. · Clinical Lymphoma Myeloma & Leukemia
Pf505 First‐in‐human Single‐ and Multiple‐ascending Dose Study of the Oral Ferroportin Inhibitor Vit‐2763 in Healthy Subjects
2019 · F. Richard, J.J. van Lier, et al. · HemaSphere
Tiotropium Respimat® versus HandiHaler®: Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials
2018 · Calverley, Peter M. A., Michael Könen-Bergmann,, et al. · Figshare
Works count: 21
Citation count: 510
H-index: 10
I10-index: 10
Year
Topic
Type